EMPAGLIFLOZIN REDUCED CIRCULATING PRO-INFLAMMATORY PRECURSOR CELL CONTENT IN PEOPLE WITHOUT DIABETES: A SUBSTUDY OF THE EMPA-HEART 2 CARDIOLINK 6 TRIAL
作者
Ehab Bakbak,Pankaj Puar,Aishwarya Krishnaraj,Daniella C. Terenzi,Tamique Mason,Adrian Quan,Hwee Teoh,Andrew T. Yan,Kim A. Connelly,C. David Mazer,David A. Hess,Subodh Verma